Loading...
XHKG
3320
Market cap4.21bUSD
Apr 03, Last price  
5.21HKD
1D
0.19%
1Q
-4.05%
Jan 2017
-40.46%
IPO
-42.24%
Name

China Resources Pharmaceutical Group Ltd

Chart & Performance

D1W1MN
P/E
8.49
P/S
0.12
EPS
0.61
Div Yield, %
5.00%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
7.35%
Revenues
270.40b
+6.41%
116,950,696,000135,749,180,000146,568,105,000156,705,203,000172,532,204,000189,689,107,000204,453,869,000200,423,023,000236,806,169,001254,106,366,001270,397,301,734
Net income
3.85b
+10.11%
2,639,517,0002,645,940,0002,850,076,0002,821,410,0003,483,036,0004,037,890,0003,286,419,0002,778,655,9293,080,673,3183,500,270,0003,854,247,000
CFO
15.55b
+42.68%
4,102,157,0004,186,722,0005,988,790,0004,119,647,0004,857,538,0008,246,965,0005,254,057,0006,277,176,00011,220,436,00010,898,714,00015,549,886,000
Dividend
Sep 10, 20240.0908 HKD/sh
Earnings
Aug 27, 2025

Profile

China Resources Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, distribution, and retail of pharmaceutical and other healthcare products in Mainland China and Hong Kong. The company operates through four segments: Pharmaceutical Manufacturing, Pharmaceutical Distribution, Pharmaceutical Retail, and Others. It offers a range of chemical drugs, Chinese medicines, and biopharmaceutical drugs, as well as nutritional and healthcare products for various therapeutic areas, including cardiovascular and cerebrovascular, alimentary tract, metabolism and endocrine, respiratory, orthopedics, oncology, medical nutrition, gastroenterology, pediatrics, genitourinary system, cough and cold, anti-infection, dermatology, infusion solutions, etc. The company also provides warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it is involved in property holding activities. As of December 31, 2021, the company operated 801 retail pharmacies under the CR Care and Teck Soon Hong brands. It distributes its products to hospitals and other medical institutions. The company was formerly known as China Resources Medications Group Limited and changed its name to China Resources Pharmaceutical Group Limited in December 2011. The company was incorporated in 2007 and is based in Wan Chai, Hong Kong. China Resources Pharmaceutical Group Limited is a subsidiary of CRH (Pharmaceutical) Limited.
URL
https://www.crpharm.com/
IPO date
Oct 28, 2016
Employees
71,000
Domiciled in
HK
Incorporated in
HK

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
270,397,302
6.41%
254,106,366
7.31%
Cost of revenue
254,880,089
242,572,804
Unusual Expense (Income)
NOPBT
15,517,213
11,533,562
NOPBT Margin
5.74%
4.54%
Operating Taxes
2,105,224
2,012,402
Tax Rate
13.57%
17.45%
NOPAT
13,411,989
9,521,160
Net income
3,854,247
10.11%
3,500,270
13.62%
Dividends
(972,360)
(942,377)
Dividend yield
3.02%
2.37%
Proceeds from repurchase of equity
(516,835)
2,874,996
BB yield
1.60%
-7.24%
Debt
Debt current
46,223,589
56,013,044
Long-term debt
17,245,795
10,984,525
Deferred revenue
788,581
867,753
Other long-term liabilities
1,118,654
1,150,113
Net debt
31,940,222
21,328,042
Cash flow
Cash from operating activities
15,549,886
10,898,714
CAPEX
(3,461,644)
(3,356,325)
Cash from investing activities
(2,067,287)
(3,298,386)
Cash from financing activities
(4,472,401)
(9,001,601)
FCF
38,294,587
25,143,697
Balance
Cash
59,266,387
32,522,319
Long term investments
(27,737,225)
13,147,208
Excess cash
18,009,297
32,964,209
Stockholders' equity
102,324,859
90,182,333
Invested Capital
163,958,828
125,491,987
ROIC
9.27%
7.11%
ROCE
8.46%
7.20%
EV
Common stock shares outstanding
6,282,510
6,282,510
Price
5.13
-18.83%
6.32
78.03%
Market cap
32,229,279
-18.83%
39,705,466
78.03%
EV
115,892,590
101,656,422
EBITDA
19,013,830
14,685,712
EV/EBITDA
6.10
6.92
Interest
2,386,312
2,855,820
Interest/NOPBT
15.38%
24.76%